Form 4: Elevance Health Executive Blair Williams Todt Reports Stock Transactions

Elevance Health's EVP, CLO & CAO, Blair Williams Todt, reports acquisition and disposal of company stock and stock options on March 1, 2024.

Summary

• On March 1, 2024, Blair Williams Todt, EVP, CLO & CAO of Elevance Health, Inc., reported transactions involving Elevance Health common stock.
• Todt disposed of 3,650 shares to cover tax liabilities at a price of $499.11 per share.
• Todt acquired 2,154 restricted share units, vesting in equal installments on March 1 of 2025, 2026, and 2027.
• Todt also acquired 6,537 performance-based restricted share units, which vested on March 1, 2024.
• Additionally, Todt acquired an option to purchase 8,312 shares of common stock at an exercise price of $499.11, vesting in three installments beginning March 1, 2025.
• Following these transactions, Todt directly owns 17,156 shares of common stock and has options to purchase 8,312 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing primarily reflects routine transactions related to executive compensation. There are no explicit positive or negative signals about the company's performance or future prospects.

Positives

• The acquisition of restricted share units and performance-based restricted share units indicates confidence in the company's future performance.
• The granting of stock options aligns the executive's interests with those of the shareholders.

Negatives

• The disposal of 3,650 shares to cover tax liabilities, while a common practice, could be perceived negatively if investors interpret it as a lack of confidence, although it is a standard procedure related to vesting.

Risks

• The vesting of restricted share units and performance-based restricted share units is contingent on continued employment and/or achievement of performance goals.
• Fluctuations in the stock price could impact the value of the stock options.

Future Outlook

The report does not contain explicit forward-looking statements, but the vesting schedules for restricted stock units and stock options suggest a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation in the healthcare industry, used by companies like UnitedHealth Group (UNH) and Cigna (CI) to align executive incentives with shareholder value.
• The vesting schedules and exercise prices are generally in line with industry practices, designed to incentivize long-term performance.
• The number of shares involved is typical for an executive at this level within a large healthcare organization.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The vesting of restricted stock units and stock options could incentivize the executive to make decisions that benefit shareholders in the long term.

Key Dates